Format

Send to

Choose Destination
Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):353-67. doi: 10.1586/egh.09.35.

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.

Author information

1
Liver Unit, Faculty of Medicine, Imperial College London, St Mary's Hospital, 10th Floor QEQM Building, South Wharf Road, London W2 1NY, UK. m.shariff@imperial.ac.uk

Abstract

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide and, owing to changes in the prevalence of the two major risk factors, hepatitis B virus and hepatitis C virus, its overall incidence remains alarmingly high in the developing world and is steadily rising across most of the developed world. Early diagnosis remains the key to effective treatment and there have been recent advances in both the diagnosis and therapy of HCC, which have made important impacts on the disease. This review outlines the epidemiological trends, risk factors, diagnostic developments and novel therapeutics for HCC, both in the developing and developed world.

PMID:
19673623
DOI:
10.1586/egh.09.35
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center